Patent · US Active

Oxindole derivative

US8053461B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2007
Grant dateNov 8, 2011
Priority date
Expiry dateFeb 20, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound or a pharmaceutically acceptable salt thereof of the present invention is represented by the following general formula (I):[wherein, R1 to R8 may have a hydrogen atom, a halogen atom, a hydroxy group, a C1-C6 alkyl group, a C2-C8 alkenyl group, a C1-C6 alkylcarbonyl group or —COOR9 (wherein R9 represents a hydrogen atom, a C1-C6 alkyl group or a C2-C8 alkenyl group) as a substituent; and X represents a sulfur atom, an oxygen atom or NR10 (wherein R10 represents a hydrogen atom, a halogen atom, a hydroxy group, a C1-C6 alkyl group, a C2-C8 alkenyl group or a C1-C6 alkoxy group)].

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.